Tesamorelin (20mg)
Description
A single-component research material supplied for controlled research environments. Tesamorelin (20 mg) is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus, widely used in research exploring GHRH receptor signaling, somatotroph axis regulation, and pulsatile growth hormone secretion dynamics in model systems.
Composition
Tesamorelin (modified GHRH(1-44) analog): 20 mg
Appearance: lyophilized powder in a sealed research vial
Research Focus (non-clinical)
Investigation of GHRH receptor binding kinetics and downstream somatotroph signaling cascades in cell culture studies
Evaluation of pulsatile growth hormone release patterns and IGF-1 axis modulation in in vitro and in vivo experimental models
Assessment of lipid metabolism biomarkers and visceral adipose tissue regulation under controlled laboratory conditions
Stability and bioactivity characterization of lyophilized Tesamorelin under laboratory storage conditions
Documentation
Lot-specific COA available
Batch and lot traceability
Important Notice
For research use only
Not for human consumption
Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
Lot-specific COA
Lyophilized for transit stability; batch traceable
Tamper-evident seal; lot & test date on each vial
No MOQ for online orders
Bulk orders for physical locations start at 25-unit minimum